We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+12.7%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$428M
AUM Growth
+$195M
Cap. Flow
+$159M
Cap. Flow %
37.3%
Top 10 Hldgs %
62.38%
Holding
48
New
8
Increased
15
Reduced
15
Closed
5

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.18M
2
BDX icon
Becton Dickinson
BDX
+$3.81M
3
CTLT
CATALENT, INC.
CTLT
+$3.07M
4
EHC icon
Encompass Health
EHC
+$2.82M
5
CRL icon
Charles River Laboratories
CRL
+$2.59M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$6.38M
2
A icon
Agilent Technologies
A
+$5.53M
3
WAT icon
Waters Corp
WAT
+$4.64M
4
UNH icon
UnitedHealth
UNH
+$3.67M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$3.24M

Sector Composition

Rank Sector Weight
1 Healthcare 53.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
26
Cigna
CI
$72.6B
$5.61M 1.31%
20,000
+5,000
+33% +$1.3M
MDT icon
27
Medtronic
MDT
$114B
$5.29M 1.24%
60,000
-7,500
-11% -$646K
ICLR icon
28
Icon
ICLR
$12.7B
$5M 1.17%
20,000
+5,000
+33% +$1.06M
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$133B
$4.93M 1.15%
14,000
-1,000
-7% -$337K
UNH icon
30
UnitedHealth
UNH
$363B
$4.81M 1.12%
10,000
-7,500
-43% -$3.67M
ACHC icon
31
Acadia Healthcare
ACHC
$2.93B
$4.78M 1.12%
60,000
-10,000
-14% -$723K
BMRN icon
32
BioMarin Pharmaceuticals
BMRN
$13.5B
$4.33M 1.01%
50,000
– –
TMO icon
33
Thermo Fisher Scientific
TMO
$223B
$3.91M 0.92%
7,500
-3,500
-32% -$1.89M
CTLT
34
DELISTED
CATALENT, INC.
CTLT
$3.04M 0.71%
+70,000
New +$3.07M
BIIB icon
35
Biogen
BIIB
$30B
$2.85M 0.67%
10,000
– –
CRL icon
36
Charles River Laboratories
CRL
$13.5B
$2.73M 0.64%
+13,000
New +$2.59M
STVN icon
37
Stevanato
STVN
$5.66B
$2.27M 0.53%
+70,000
New +$1.97M
AVTR icon
38
Avantor
AVTR
$9.23B
$1.54M 0.36%
+75,000
New +$1.52M
ALNY icon
39
Alnylam Pharmaceuticals
ALNY
$29.5B
$1.52M 0.36%
8,000
+500
+7% +$99.1K
CYH icon
40
Community Health Systems
CYH
$400M
$1.32M 0.31%
+300,000
New +$1.28M
ARGX icon
41
argenx
ARGX
$54.1B
$1.17M 0.27%
+3,000
New +$1.18M
GRFS
42
Grifois
GRFS
$5.4B
$576K 0.13%
+62,843
New +$519K
SRPT icon
43
Sarepta Therapeutics
SRPT
$1.89B
$93K 0.02%
811
-12,189
-94% -$1.57M
A icon
44
Agilent Technologies
A
$42.1B
– –
-40,000
Closed -$5.53M
ABBV icon
45
AbbVie
ABBV
$439B
– –
-40,000
Closed -$6.38M
OPCH icon
46
Option Care Health
OPCH
$3.55B
– –
-80,000
Closed -$2.54M
WAT icon
47
Waters Corp
WAT
$40.8B
– –
-15,000
Closed -$4.64M
SGEN
48
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-16,000
Closed -$3.24M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q2 2023 Portfolio in Review

As of Q2 2023, Sivik Global Healthcare held 48 positions worth $428M, up 84% from $233M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sivik Global Healthcare deployed $159M of net new capital in Q2 2023, opening 8 new positions and adding to 15 existing holdings. Its largest new stake was CATALENT, INC.: 70,000 shares worth $3.04M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 93% a quarter earlier.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.67M trimmed.

  • Sivik Global Healthcare's largest Q2 2023 buy was CATALENT, INC.: 70,000 shares worth $3.04M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q2 2023, an estimated $4.18M increase.
  • Sivik Global Healthcare's biggest Q2 2023 reduction was UnitedHealth, cutting an estimated $3.67M.
  • Sivik Global Healthcare fully exited AbbVie in Q2 2023, selling an estimated $6.38M.
  • Sivik Global Healthcare's ten largest holdings make up 62% of its $428M portfolio in Q2 2023.
  • Sivik Global Healthcare opened 8 new positions and closed 5 in Q2 2023.
  • Sivik Global Healthcare's portfolio value rose 84% quarter-over-quarter to $428M.

Based on Sivik Global Healthcare's 13F filing for Q2 2023, filed 9 Aug 2023.